Pérez-Romasanta

Luis A. Pérez-Romasanta: DART phase II trial results

Luis A. Pérez-Romasanta, Radiation Oncologist affiliated with Salamanca University Hospital, shared a post on X:

“ESTRO25 PROSTATE:

  • DART phase II trial(oligomets PSMA+).
  • SBRT+/-Darolutamide.
  • Tox & QL results.”

Luis A. Pérez-Romasanta: DART phase II trial results

More posts featuring ESTRO25 on OncoDaily.

cancer darolutamide DART phase II trial ESTRO25 fight against cancer Global fight against cancer Luis A. Pérez-Romasanta OncoDaily Oncology Radiation Oncologist Salamanca University Hospital SBRT